NCT03474965 · Interventional trial
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
Overall registry status Completed
Phase 2
Conditions Sickle Cell Disease (SCD)
Delaware Valley sites
- Childrens Hospital Of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory